Profile
Michael Steiner has a current job as a Member-Supervisory Board at Bitop AG.
Michael Steiner active positions
Companies | Position | Start |
---|---|---|
Bitop AG
Bitop AG Household/Personal CareConsumer Non-Durables Part of UWH Beteiligungsgesellschaft mbH, Bitop AG is a German company that specializes in the production and application of ectoin® and other extremolytes for pharmaceutical, cosmetics, life science, and animal care industries. The company is based in Witten, Germany. The company offers patent-protected OTC medical devices, highly effective cosmetic ingredients, and unique animal health and care products. Bitop's products include medicine for coughing and colding, allergic diseases of the eye, and health and well-being. The company also offers cosmetic active ingredients and life science solutions for the stabilization of biomolecules. Bitop's recent in vitro study on lung cells with SARS-CoV-2 shows virus-blocking efficacy of Bitop ectoin®. Bitop was founded in 1993 by Thomas Schwarz, and Michael Braig has been the CEO of the company since 2019. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Bitop AG
Bitop AG Household/Personal CareConsumer Non-Durables Part of UWH Beteiligungsgesellschaft mbH, Bitop AG is a German company that specializes in the production and application of ectoin® and other extremolytes for pharmaceutical, cosmetics, life science, and animal care industries. The company is based in Witten, Germany. The company offers patent-protected OTC medical devices, highly effective cosmetic ingredients, and unique animal health and care products. Bitop's products include medicine for coughing and colding, allergic diseases of the eye, and health and well-being. The company also offers cosmetic active ingredients and life science solutions for the stabilization of biomolecules. Bitop's recent in vitro study on lung cells with SARS-CoV-2 shows virus-blocking efficacy of Bitop ectoin®. Bitop was founded in 1993 by Thomas Schwarz, and Michael Braig has been the CEO of the company since 2019. | Consumer Non-Durables |
- Stock Market
- Insiders
- Michael Steiner